Related references
Note: Only part of the references are listed.Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR
Laura M. Wingler et al.
SCIENCE (2020)
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
PHARMACOLOGICAL REVIEWS (2019)
Can Adding Constitutive Receptor Activity Redefine Biased Signaling Quantification?
Bin Zhou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics
Mie Fabricius Pedersen et al.
NEUROPHARMACOLOGY (2019)
A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data
Peter Buchwald
FRONTIERS IN PHARMACOLOGY (2019)
An evaluation of the operational model when applied to quantify functional selectivity
Xiao Zhu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
A method for the quantification of biased signalling at constitutively active receptors
David A. Hall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Is the Quest for Signaling Bias Worth the Effort?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2018)
Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?
Martin C. Michel et al.
MOLECULAR PHARMACOLOGY (2018)
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias
J. Daniel Hothersall et al.
NEUROPHARMACOLOGY (2017)
Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias
Frederick J. Ehlert et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach
H. Ongun Onaran et al.
SCIENTIFIC REPORTS (2017)
A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification
Peter Buchwald
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
The number of subjects per variable required in linear regression analyses
Peter C. Austin et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
A Novel Method for Analyzing Extremely Biased Agonism at G Protein-Coupled Receptors
Edward L. Stahl et al.
MOLECULAR PHARMACOLOGY (2015)
Minireview: More Than Just a Hammer: Ligand Bias and Pharmaceutical Discovery
Louis M. Luttrell
MOLECULAR ENDOCRINOLOGY (2014)
Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective
Jeremy Shonberg et al.
MEDICINAL RESEARCH REVIEWS (2014)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The Hill equation and the origin of quantitative pharmacology
Rudolf Gesztelyi et al.
ARCHIVE FOR HISTORY OF EXACT SCIENCES (2012)
Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4
R. J. Slack et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Sudarshan Rajagopal et al.
MOLECULAR PHARMACOLOGY (2011)
A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets
Peter Buchwald
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2011)
Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias
Karen J. Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M-3 Receptor
David A. Sykes et al.
MOLECULAR PHARMACOLOGY (2009)
The Hill equation: a review of its capabilities in pharmacological modelling
Sylvain Goutelle et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Sample sizes when using multiple linear regression for prediction
Gregory T. Knofczynski et al.
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT (2008)
Estimation of agonist activity at G protein-coupled receptors:: Analysis of M2 muscarinic receptor signaling through Gi/o, Gs, and G15
Michael T. Griffin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A general bilinear model to describe growth or decline time profiles
Peter Buchwald
MATHEMATICAL BIOSCIENCES (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The receptor concept: pharmacology's big idea
HP Rang
BRITISH JOURNAL OF PHARMACOLOGY (2006)
General linearized biexponential model for QSAR data showing bilinear-type distribution
P Buchwald
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig et al.
PHARMACOLOGICAL REVIEWS (2003)
The emergence of the drug receptor theory
AH Maehle et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
